Gellan co-polysaccharide micellar solution of budesonide for allergic anti-rhinitis: An in vitro appraisal

International Journal of Biological Macromolecules

Volumn 68, Issue , 2014, Pages 241-246

  Maiti, Sabyasachi ^a   Chakravorty, Amrita ^a   Chowdhury, Moumita ^a  

^a GUPTA COLLEGE OF TECHNOLOGICAL SCIENCES   (India)

Author keywords

Anti rhinitis; Budesonide; Dissolution efficiency; Gellan polysaccharide; Polysaccharide micelles; Sorbitan monooleate

Indexed keywords

ALKYL GROUP; AMPHOPHILE; BUDESONIDE; COPOLYMER; GELLAN; POLYSACCHARIDE; WATER; BACTERIAL POLYSACCHARIDE; MICELLE; SOLUTION AND SOLUBILITY;

ALLERGIC RHINITIS; AQUEOUS SOLUTION; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG INCOMPATIBILITY; DRUG RELEASE; DRUG SOLUBILITY; DRUG SOLUTION; DRUG STABILITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTRANASAL DRUG ADMINISTRATION; MICELLE; NOSE MUCUS; SIMULATION; ZETA POTENTIAL; KINETICS; MOLECULAR WEIGHT; PH; RHINITIS, ALLERGIC; SOLUTION AND SOLUBILITY;

BUDESONIDE; CALORIMETRY, DIFFERENTIAL SCANNING; HYDROGEN-ION CONCENTRATION; KINETICS; MICELLES; MOLECULAR WEIGHT; POLYSACCHARIDES, BACTERIAL; RHINITIS, ALLERGIC; SOLUTIONS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84901228189     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2014.05.003     Document Type: Article

References (40)

1. Thompson D., Chaubal M.V. Drug Deliv. Technol. 2000, 2:34-38.
2. Torchilin V.P. Cell Mol. Life Sci. 2004, 61:2549-2559.
3. Bhise S.B., Yadav A.V., Avachat A.M., Malayandi R. Asian J. Pharm. 2008, 2:201-215.
4. Yalkowsky S.H., Roseman T.J. Techniques of Solubilization of Drugs 1981, 91-134. Marcel Dekker, New York. S.H. Yalkowsky (Ed.).
5. Ray R., Kibbe A.H., Rowe R., Shleskey P., Weller P. Handbook of Pharmaceutical Excipients 2003, APhA Publications, Washington DC. fourth ed.
6. Rosen M.J. Surfactants and Interfacial Phenomena 1989, Wiley Interscience, New York. second ed.
7. Djupesland P.G. Drug Deliv. Transl. Res. 2013, 3:42-62.
8. Salib R.J., Howarth P.H. Drug Safe 2003, 26:863-893.
9. May J.R., Smith P.H. Pharmacotherapy: A Pathophysiologic Approach 2008, 1565-1575. McGraw-Hill, New York. J.T. Dipiro, R.L. Talbert, G.C. Yee, G. Matzke, B. Wells, L.M. Posey (Eds.).
10. Sur D.K., Scandale S. Am. Fam. Physician 2010, 81:1440-1446.
11. Nishiyama N., Kataoka K. Pharmacol. Ther. 2006, 112:630-648.
12. Lukyanov A.N., Torchilin V.P. Adv. Drug Deliv. Rev. 2004, 56:1273-1289.
13. Miller D.W., Batrakova E.V., Waltner T.O., Yu A.V., Kabanov A.V. Bioconj. Chem. 1997, 8:649-657.
14. Trubetskoy V.S., Gazelle G.S., Wolf G.L., Torchilin V.P. J. Drug Target 1997, 4:381-388.
15. Yokoyama M., Miyauchi M., Yamada N., Okano T., Sakurai Y., Kataoka K., Inoue S. Cancer Res. 1990, 50:1693-1700.
16. Kim S.Y., Shin I.G., Lee Y.M., Cho C.G., Sung Y.K. J. Control Rel. 1998, 51:13-22.
17. Hagan S.A., Coombes A.G.A., Garnett M.C., Dunn S.E., Davies M.C., Illum L., Davis S.S., Harding S.E., Purkiss S., Gellert P.R. Langmuir 1996, 12:2153-2161.
18. Andrianov A.K., Payne L.G. Adv. Drug Deliv. Rev. 1998, 34:155-170.
19. Francis M.F., Cristea M., Winnik F.M. Pure Appl. Chem. 2004, 76:1321-1335.
20. Jiang G.-B., Quan D., Liao K., Wang H. Mol. Pharm. 2006, 3:152-160.
21. Mekhail G.M., Kamel A.O., Awad G.A., Mortada N.D. Int. J. Biol. Macromol. 2012, 51:351-363.
22. Jeong Y.-I.I., Seo D.-H., Kim D.-G., Choi C., Jang M.-K., Nah J.-W., Park Y. Macromol. Res. 2009, 17:538-543.
23. Izumi Y., Kikuta N., Sakai K., Takezawa H. Carbohydr. Polym. 1996, 30:121-127.
24. S.R. Sudhamani, M.S. Prasad, S.K. Udaya, Food Hydrocoll. 17 (2003) 245-250.
25. Kemp W. Organic Spectroscopy 1991, MacMillan Press Ltd., London. third ed.
26. Nidhin M., Indumathy R., Sreeram K.J., Balachandran U. Bull. Mater. Sci. 2008, 31:93-96.
27. Bajgai M.P., Aryal S., Lee D.R., Park S.-J., Kim H.Y. Colloid Polym. Sci. 2008, 286:517-524.
28. Francis M.F., Cristea M., Yang Y., Winnik F.M. Pharm. Res. 2005, 22:209-219.
29. Li X., You J., Cui F., Du Y., Yuan H., Hu F. Asian J. Pharm. Sci. 2008, 3:80-87.
30. Mu L., Feng S.S. J. Control Rel. 2001, 76:239-254.
31. Martin T.M., Bandi N., Shulz R., Roberts C.B. AAPS PharmSciTech 2002, 3:1-11.
32. Gill K.K., Nazzal S., Kaddoumi A. Eur. J. Pharm. Biopharm. 2011, 79:276-284.
33. Khan K.A. J. Pharm. Pharmacol. 1975, 27:48-49.
34. Costa P., Lobo J.M.S. Euro. J. Pharm. Sci. 2001, 13:123-133.
35. Corrigan D.O., Healy A.M., Corrigan O.I. Eur. J. Pharm. Biopharm. 2006, 62:295-305.
36. Korsmeyer R.W., Gurny R., Doelker E., Buri P., Peppas N.A. Int. J. Pharm. 1983, 15:25-35.
37. Cortesi R., Ravani L., Menegatti E., Esposito E., Ronconi F. Indian J. Pharm. Sci. 2012, 5:415-421.
38. Parmar J.J., Singh D.J., Hegde D.D., Lohade A.A., Soni P.S., Samad A., Menon M.D. Indian J. Pharm. Sci. 2010, 72:442-448.
39. Sahib M.N., Darwis Y., Peh K.K., Abdulameer S.A., Tan Y.T. Int. J. Nanomedicine 2011, 6:2351-2366.
40. Raval M.K., Ramani R.V., Sheth N.R. Int. J. Pharm. Invest. 2013, 3:203-211.